Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) CFO Sandra Wallach sold 18,142 shares of the firm's stock in a transaction on Friday, February 21st. The shares were sold at an average price of $3.13, for a total value of $56,784.46. Following the completion of the sale, the chief financial officer now owns 678,000 shares in the company, valued at approximately $2,122,140. This represents a 2.61 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link.
Amprius Technologies Price Performance
Shares of AMPX stock traded up $0.02 during trading hours on Friday, hitting $2.56. The stock had a trading volume of 1,644,454 shares, compared to its average volume of 3,565,154. The firm has a market capitalization of $270.42 million, a PE ratio of -5.68 and a beta of 2.45. The stock's 50 day moving average is $3.10 and its 200 day moving average is $2.00. Amprius Technologies, Inc. has a twelve month low of $0.61 and a twelve month high of $4.20.
Institutional Trading of Amprius Technologies
Large investors have recently bought and sold shares of the business. Rhumbline Advisers increased its stake in Amprius Technologies by 49.4% in the fourth quarter. Rhumbline Advisers now owns 9,739 shares of the company's stock valued at $27,000 after purchasing an additional 3,222 shares during the period. Mercer Global Advisors Inc. ADV acquired a new stake in shares of Amprius Technologies during the fourth quarter worth about $28,000. Kingswood Wealth Advisors LLC purchased a new position in shares of Amprius Technologies during the fourth quarter worth about $30,000. O Dell Group LLC acquired a new position in Amprius Technologies in the 4th quarter valued at about $35,000. Finally, Bank of America Corp DE raised its stake in Amprius Technologies by 31.1% during the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company's stock valued at $36,000 after acquiring an additional 3,055 shares during the last quarter. Institutional investors and hedge funds own 5.04% of the company's stock.
Analyst Ratings Changes
Several equities analysts have commented on the stock. HC Wainwright reiterated a "buy" rating and issued a $10.00 price target on shares of Amprius Technologies in a research note on Monday, November 11th. Cantor Fitzgerald initiated coverage on shares of Amprius Technologies in a research report on Tuesday, January 21st. They set an "overweight" rating and a $10.00 price objective for the company. Finally, Northland Securities upped their target price on shares of Amprius Technologies from $4.00 to $10.00 and gave the company an "outperform" rating in a report on Friday, January 10th. Six equities research analysts have rated the stock with a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, the stock presently has a consensus rating of "Buy" and a consensus price target of $9.29.
View Our Latest Analysis on AMPX
Amprius Technologies Company Profile
(
Get Free Report)
Amprius Technologies, Inc produces and sells ultra-high energy density lithium-ion batteries for mobility applications. The company offers silicon nanowire anode batteries. Its batteries are primarily used for existing and emerging aviation applications, including unmanned aerial systems, such as drones and high-altitude pseudo satellites.
Featured Stories

Before you consider Amprius Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amprius Technologies wasn't on the list.
While Amprius Technologies currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.